Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast for Prevention of Paclitaxel-Induced Peripheral Neuropathy
NCT05884281Phase 2Unknown
- Sponsor
- Mansoura University
- Start
- Jul 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of roflumilast in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Mansoura University. Status: unknown.
02
Drugs
roflumilast
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT05884281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05884281.